期刊文献+

宫颈癌标本中HPV16的早期基因E6、E7和LCR的测定分析

Analysis on HIV16 early genes E6,E7 and LCR detection in cervical cancer specimens
原文传递
导出
摘要 目的:分析宫颈癌标本中HPV16的E6,E7和LCR(long control region,LCR)的变异。方法:对125份HPV16阳性的宫颈癌标本利用PCR扩增HPV16 E6、E7和LCR片段,并对PCR扩增产物进行DNA序列测定。结果:在E6最常见的变异为T350G(100.0%),在E7区最常见的变异为T789C(87.5%),而在LCR最常见的变异为G7521A(91.1%)。此外,在E6发现一个新变异T527A,在LCR区发现4个新变异C13T,A7636C,C7678T和G7799A,而E7区高度保守,LCR变异的位点集中于YY1转录因子结合位点。结论:宫颈癌中HPV16存在E6、E7和LCR变异,对高危型HPV变异的分析有助于HPV的诊断和疫苗的设计。 Objective: To analyze the variations of HPV16 E6,E7 and long control region(LCR) in cervical cancer specimens.Methods: HPV16 E6,E7 and LCR segments in 125 positive HPV16 cervical cancer specimens were amplified,and the amplification products were detected by DNA sequencing.Results: The most common variation of E6 was T350G(100.0%),the most common variation of E7 was T789C(87.5%),and the most common variation of LCR was G7521A(91.1%).In addition,one new variation of E6-T527A was found,four new variations of LCR-C13T,A7636C,C7678T and G7799A were found,the locations of LCR variations focused in binding sites of YY1 transcription factor.Conclusion: HPV16 E6,E7 and LCR variations exist in cervical cancer,analyzing high risk HPV variations is helpful to diagnosis of HPV and design of vaccine.
出处 《中国妇幼保健》 CAS 北大核心 2013年第22期3619-3621,共3页 Maternal and Child Health Care of China
关键词 乳头瘤病毒 分子遗传 宫颈癌 Human papillomavirus Molecular genetics Cervical cancer
  • 相关文献

参考文献13

  • 1邵佳,陈曾燕,王洁,马蓉.实时荧光定量PCR检测宫颈癌患者血浆HPV的临床意义[J].中国肿瘤外科杂志,2010,2(5):288-291. 被引量:6
  • 2乔友林,章文华,李凌,潘秦镜,杨玲,吴令英,戍寿德,李爱玲,张询,任生达,Belinson J.子宫颈癌筛查方法的横断面比较研究[J].中国医学科学院学报,2002,24(1):50-53. 被引量:351
  • 3Schiffman MH, Brinton LA. The epidemiology of cervical carci- nogenesis [J] . Cancer, 1995, 76 (10 suppl) : 1888.
  • 4Phelps WC, Alexander KA. Antiviral therapy for human papil- lomaviruses: rational and prospects [ J ] . Ann Intern Med, 1995, 123 (5): 368.
  • 5Londesborough P, Ho L, Terry G, et al. Human papillomavir- us genotype as a predictor of persistence and development of high - grade lesions in women with minor cervical abnormalities [J] . IntJ Cancer, 1996, 69 (5): 364.
  • 6Ellis JR, Keating PJ, Baird J, et al. The association of an HPV16 oncogene variant with HLA - B7 has implications for vaccine design in cervical cancer [J]. Nat Meal, 1995, 1 (5): 464.
  • 7Andersson S, Alemi M, Rylander E, et al. Uneven distribu- tion of HPV 16 E6 prototype and variant (L83V) oneoprotein in cervical neoplastic lesions[J] .Br J Cancer, 2000, 83 (3) : 307.
  • 8Hu X, Pang T, Guo Z, et al. HPV16 E6 gene variations in invasive cervical squarnous eell carcinoma and cancer in situ from Russian patients [J].Br J Cancer, 2001, 84 (6): 791.
  • 9de Boer MA, Peters LA, Aziz MF, et al. Human papilloma- virus type 16 E6, E7, and L1 variants in cervical cancer in In- donesia, Suriname, and the Netherlands [ J ] . Gynecol On- col, 2004, 94 (2): 488.
  • 10Wu Y, Chen Y, Li L, et al. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China [ J ] . J Gen Virol, 2006, 87 (pt 5) : 1181.

二级参考文献11

  • 1卫生部肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1979,1..
  • 2Belinson SE,Belinson JL.Human papillomavirus DNA testing for cervical cancer screening:practical aspects in developing countries[J].Mol Diagn Ther,14(4):215-222.
  • 3Ho CM,Yang SS,Chien TY,et al.Detection and quantitation of human papillomavirus type 16,18 and 52 DNA in the peripheral blood of cervical cancer patients[J].Gynecol Oncol,2005,99(3):615-621.
  • 4Kay P,Allan B,Denny L,et al.Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer[J].J Med Virol,2005,75(3):435-439.
  • 5Yang HJ,Liu VW,Tsang PC,et al.Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer[J].Int J Gynecol Cancer,2004,14(5):903-910.
  • 6Lowy DR,Solomon D,Hildesheim A,et al.Human papillomavirus infection and the primary and secondary prevention of cervical cancer[J].Cancer,2008,113(7 Suppl):1980-1993.
  • 7Vlassov VV,Laktionov PP,Rykova EY.Circulating nucleic acids as a potential source for cancer biomarkers[J].Curr Mol Med,10(2):142-165.
  • 8Lo YM,Chan AT,Chan LY,et al.Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA[J].Cancer Res,2000,60(24):6878-6881.
  • 9Duenas A,Saldivar C,Castillero C,et al.A case of bilateral seminoma in the setting of persistent mullerian duct syndrome[J].Rev Invest Clin,2001,53(2):193-196.
  • 10Pornthanakasem W,Shotelersuk K,Termrungruanglert W,et al.Human papillomavirus DNA in plasma of patients with cervical cancer[J].BMC Cancer,2001,1:2.

共引文献355

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部